Medical Developments International | MVP - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Akebia Therapeutics USD 23.53M 3.19M 2025-12
Alaunos Therapeutics USD 447K 138K 2026-03
Avita Medical AUD 19.03M 1.95M 2025-12
Clinuvel Pharmaceuticals AUD 3.85M 5.27M 2025-12
Dianthus Therapeutics USD 12.47M 5.89M 2026-03
Genetic Signatures AUD 908K 31K 2025-12
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
Medical Developments International AUD 2.84M 4.19M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Organon & Co USD 434M 10M 2026-06
Paradigm Biopharmaceuticals AUD 2.83M 1.22M 2025-12
PYC Therapeutics AUD 328.4K 1.8M 2025-12
Starpharma Holdings AUD 4.42M 2.86M 2025-12
Tectonic Therapeutic USD 6.43M 2.99M 2026-03
Telix Pharmaceuticals AUD 107.02M 13.54M 2026-06
Viatris USD 1.13B 205.7M 2026-06
Xeris Pharmaceuticals USD 53.14M 10.51M 2026-03